Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis. [electronic resource] by
- Terpos, E
- Kastritis, E
- Roussou, M
- Heath, D
- Christoulas, D
- Anagnostopoulos, N
- Eleftherakis-Papaiakovou, E
- Tsionos, K
- Croucher, P
- Dimopoulos, M A
Producer: 20090127
In:
Leukemia vol. 22
Availability: No items available.
|
|
|
4.
|
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma. [electronic resource] by
- Dimopoulos, M A
- Roussou, M
- Gkotzamanidou, M
- Nikitas, N
- Psimenou, E
- Mparmparoussi, D
- Matsouka, C
- Spyropoulou-Vlachou, M
- Terpos, E
- Kastritis, E
Producer: 20130404
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
5.
|
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma. [electronic resource] by
- Roussou, M
- Tasidou, A
- Dimopoulos, M A
- Kastritis, E
- Migkou, M
- Christoulas, D
- Gavriatopoulou, M
- Zagouri, F
- Matsouka, C
- Anagnostou, D
- Terpos, E
Producer: 20091207
In:
Leukemia vol. 23
Availability: No items available.
|
|
|
6.
|
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. [electronic resource] by
- Dimopoulos, M A
- Kastritis, E
- Bamia, C
- Melakopoulos, I
- Gika, D
- Roussou, M
- Migkou, M
- Eleftherakis-Papaiakovou, E
- Christoulas, D
- Terpos, E
- Bamias, A
Producer: 20090319
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
|
7.
|
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies. [electronic resource] by
- Dimopoulos, M A
- Kastritis, E
- Christoulas, D
- Migkou, M
- Gavriatopoulou, M
- Gkotzamanidou, M
- Iakovaki, M
- Matsouka, C
- Mparmparoussi, D
- Roussou, M
- Efstathiou, E
- Terpos, E
Producer: 20101112
In:
Leukemia vol. 24
Availability: No items available.
|
|
|
8.
|
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT. [electronic resource] by
- Terpos, E
- Christoulas, D
- Kastritis, E
- Roussou, M
- Migkou, M
- Eleutherakis-Papaiakovou, E
- Gavriatopoulou, M
- Gkotzamanidou, M
- Kanellias, N
- Manios, E
- Papadimitriou, C
- Dimopoulos, M A
Producer: 20140616
In:
Leukemia vol. 28
Availability: No items available.
|
|
|
9.
|
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. [electronic resource] by
- Kastritis, E
- Terpos, E
- Moulopoulos, L
- Spyropoulou-Vlachou, M
- Kanellias, N
- Eleftherakis-Papaiakovou, E
- Gkotzamanidou, M
- Migkou, M
- Gavriatopoulou, M
- Roussou, M
- Tasidou, A
- Dimopoulos, M A
Producer: 20130604
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
10.
|
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents. [electronic resource] by
- Moulopoulos, L A
- Dimopoulos, M A
- Christoulas, D
- Kastritis, E
- Anagnostou, D
- Koureas, A
- Roussou, M
- Gavriatopoulou, M
- Migkou, M
- Iakovaki, M
- Gkotzamanidou, M
- Tasidou, A
- Terpos, E
Producer: 20100706
In:
Leukemia vol. 24
Availability: No items available.
|
|
|
11.
|
Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive antibiotic prophylaxis. [electronic resource] by
- Eleutherakis-Papaiakovou, E
- Dimopoulos, M-A
- Kastritis, E
- Christoulas, D
- Roussou, M
- Migkou, M
- Gavriatopoulou, M
- Fotiou, D
- Panagiotidis, I
- Ziogas, D C
- Kanellias, N
- Papadimitriou, C
- Terpos, E
Producer: 20180625
In:
Bone marrow transplantation vol. 52
Availability: No items available.
|
|
|
12.
|
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. [electronic resource] by
- Dimopoulos, M A
- Kastritis, E
- Michalis, E
- Tsatalas, C
- Michael, M
- Pouli, A
- Kartasis, Z
- Delimpasi, S
- Gika, D
- Zomas, A
- Roussou, M
- Konstantopoulos, K
- Parcharidou, A
- Zervas, K
- Terpos, E
Producer: 20120612
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
13.
|
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG). [electronic resource] by
- Kastritis, E
- Zervas, K
- Symeonidis, A
- Terpos, E
- Delimbassi, S
- Anagnostopoulos, N
- Michali, E
- Zomas, A
- Katodritou, E
- Gika, D
- Pouli, A
- Christoulas, D
- Roussou, M
- Kartasis, Z
- Economopoulos, T
- Dimopoulos, M A
Producer: 20090707
In:
Leukemia vol. 23
Availability: No items available.
|
|
|
14.
|
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma. [electronic resource] by
- Terpos, E
- Christoulas, D
- Kastritis, E
- Bagratuni, T
- Gavriatopoulou, M
- Roussou, M
- Papatheodorou, A
- Eleutherakis-Papaiakovou, E
- Kanellias, N
- Liakou, C
- Panagiotidis, I
- Migkou, M
- Kokkoris, P
- Moulopoulos, L A
- Dimopoulos, M A
Producer: 20171120
In:
Blood cancer journal vol. 6
Availability: No items available.
|
|
|
15.
|
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. [electronic resource] by
- Dimopoulos, M A
- Roussou, M
- Gavriatopoulou, M
- Fotiou, D
- Ziogas, D C
- Migkou, M
- Panagiotidis, I
- Eleutherakis-Papaiakovou, E
- Kanellias, N
- Psimenou, E
- Marinaki, S
- Bacharaki, D
- Mparmparoussi, D
- Matsouka, C
- Giannouli, S
- Terpos, E
- Kastritis, E
Producer: 20180829
In:
Blood cancer journal vol. 7
Availability: No items available.
|
|
|
16.
|
Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib. [electronic resource] by
- Kastritis, E
- Gavriatopoulou, M
- Roussou, M
- Fotiou, D
- Ziogas, D C
- Migkou, M
- Eleutherakis-Papaiakovou, E
- Panagiotidis, I
- Kanellias, N
- Psimenou, E
- Papadopoulou, E
- Pamboucas, C
- Manios, E
- Gakiopoulou, H
- Ntalianis, A
- Tasidou, A
- Giannouli, S
- Terpos, E
- Dimopoulos, M A
Producer: 20180320
In:
Blood cancer journal vol. 7
Availability: No items available.
|
|
|
17.
|
Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma. [electronic resource] by
- Kastritis, E
- Zagouri, F
- Symeonidis, A
- Roussou, M
- Sioni, A
- Pouli, A
- Delimpasi, S
- Katodritou, E
- Michalis, E
- Michael, M
- Hatzimichael, E
- Vassou, A
- Repousis, P
- Christophoridou, A
- Kartasis, Z
- Stefanoudaki, E
- Megalakaki, C
- Giannouli, S
- Kyrtsonis, M-C
- Konstantopoulos, K
- Spyroupoulou-Vlachou, M
- Terpos, E
- Dimopoulos, M A
Producer: 20141203
In:
Leukemia vol. 28
Availability: No items available.
|